Development of Minimally Invasive Methodology for Diabetyping to Personalise Treatment to Realise Remission and Reversal of Type 2 Diabetes

NCT06125119 · clinicaltrials.gov ↗
UNKNOWN
Status
57
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

TNO